Filing Details
- Accession Number:
- 0001209191-21-054913
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2021-09-03 20:23:08
- Reporting Period:
- 2021-09-01
- Accepted Time:
- 2021-09-03 20:23:08
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1496323 | Igm Biosciences Inc. | IGMS | Pharmaceutical Preparations (2834) | 770349194 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1787362 | Bruce Keyt | C/O Igm Biosciences, Inc. 325 E. Middlefield Road Mountain View CA 94043 | Chief Scientific Officer | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2021-09-01 | 2,500 | $0.93 | 5,557 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2021-09-01 | 1,256 | $71.79 | 4,301 | No | 4 | F | Direct | |
| Common Stock | Disposition | 2021-09-03 | 1,244 | $70.69 | 3,057 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | F | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Stock Option (right to buy) | Disposition | 2021-09-01 | 2,500 | $0.00 | 2,500 | $0.93 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 5,264 | 2025-03-10 | No | 4 | M | Direct |
Reported Non-Derivative Holdings
| Sec. Name | Remaning Holdings | Nature of Ownership | Explanation |
|---|---|---|---|
| Common Stock | 1,013 | Indirect | See footnote |
Footnotes
- The option exercise and sale were effected pursuant to a Rule 10b5-1 trading plan entered into by the Reporting Person.
- Represents shares withheld by the Issuer to pay the exercise price and taxes pursuant to the "net exercise" of 2,500 option shares.
- This transaction was executed in multiple trades at prices ranging from $70.02 to $71.59. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price.
- The shares are held directly by the reporting person's spouse.
- The shares subject to the option are vested and exercisable as of the date hereof.
Billionaire Hedge Funds
